Talha Badar, Hematology/Oncology Specialist at Mayo Clinic, shared a post on X:
“Pleased to share this Special Issue in Cancers:
‘Evolving Paradigms in Acute Myeloid Leukemia: From Molecular Risk to Targeted Treatment’
Welcoming submissions in AML spanning molecular risk, targeted therapy, MRD, relapse biology, transplant, and real-world outcomes.
Deadline: May 25, 2026”
Other Articles Featuring Talha Badar on OncoDaily.